239 related articles for article (PubMed ID: 2750638)
1. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
Plusa T; Józefczak E; Raczka A
Allergol Immunopathol (Madr); 1989; 17(1):29-32. PubMed ID: 2750638
[TBL] [Abstract][Full Text] [Related]
2. [Theophylline in the serum and bronchoalveolar lavage fluid (BALF) in patients with bronchospastic conditions].
Płusa T; Wasek Z; Kruszewski J; Józefczak E; Raczka A
Pneumonol Pol; 1988 Nov; 56(11):523-7. PubMed ID: 3075272
[No Abstract] [Full Text] [Related]
3. Immunobiochemical evaluation of bronchoalveolar lavage (BAL) in atopic bronchial asthma, chronic bronchitis and bronchiectasis.
Plusa T; Wäsek Z
Allergol Immunopathol (Madr); 1987; 15(4):209-13. PubMed ID: 3318350
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of bronchoalveolar lavage (BAL) fluid in atopic bronchial asthma, chronic bronchitis and sarcoidosis patients.
Płusa T; Tchórzewski H
Allerg Immunol (Leipz); 1990; 36(1):11-5. PubMed ID: 2189286
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of theopek in bronchial asthma and chronic bronchitis].
Korzh OB
Ter Arkh; 1990; 62(3):82-4. PubMed ID: 2368005
[TBL] [Abstract][Full Text] [Related]
6. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H
Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
[TBL] [Abstract][Full Text] [Related]
7. [Theophylline pharmacokinetics in elderly persons and in patients with bronchial asthma or chronic obstructive bronchitis].
Mazurek W; Halawa B
Wiad Lek; 1986 Nov; 39(21):1451-6. PubMed ID: 3577156
[No Abstract] [Full Text] [Related]
8. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
[TBL] [Abstract][Full Text] [Related]
9. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
[TBL] [Abstract][Full Text] [Related]
10. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
11. Activity of angiotensin I converting enzyme in sarcoidosis, atopic bronchial asthma and acute bronchitis.
Plusa T; Chcialowski A; Piechota W; Pirozyński M
Allergol Immunopathol (Madr); 1990; 18(4):217-21. PubMed ID: 2176061
[TBL] [Abstract][Full Text] [Related]
12. [The pharmacokinetics of theopek--a new Soviet prolonged-action drug form of theophylline--in patients with bronchial asthma].
Belousov IuB; Abazova FI; Kholodov LE; Chervinskaia TA; Sokolov AV
Farmakol Toksikol; 1989; 52(5):63-8. PubMed ID: 2599082
[TBL] [Abstract][Full Text] [Related]
13. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
van der Vet AP; Kreukniet J; Drost RH; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
Hirsch H
Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
[TBL] [Abstract][Full Text] [Related]
17. Reliability of salivary theophylline concentration monitoring in children with bronchial asthma following the administration of different drug formulations.
Boner AL; Valletta EA; Plebani M; Biancotto R; Bellanti JA
Allergol Immunopathol (Madr); 1985; 13(5):393-8. PubMed ID: 4083233
[TBL] [Abstract][Full Text] [Related]
18. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
Menendez R; Kelly HW; Howick J; McWilliams BC
Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of bradykinin levels and activation of Tame-esterase in Bronchial alveolar lavage fluid of patients with bronchial asthma].
Gawlik R; Baumgarten C; Kunkel G; Rogala E
Pneumonol Alergol Pol; 1995; 63(5-6):268-72. PubMed ID: 7581056
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of theophylline treatment by saliva and plasma concentrations.
Juntunen-Backman K; Backman A; Björkstén F; Finnilä MJ
Allergol Immunopathol (Madr); 1988; 16(1):5-9. PubMed ID: 3381714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
